Hiroyasu Shoda

The Tumor Immune Microenvironment Is Associated With Recurrence in Early-Stage Lung Adenocarcinoma

T. Ohira, Y. Miyata, M. Takeda, 2024, JTO clinical and research reports.

NOTCH1 and CREBBP co‐mutations negatively affect the benefit of adjuvant therapy in completely resected EGFR‐mutated NSCLC: translational research of phase III IMPACT study

Y. Ohde, H. Akamatsu, H. Tada, 2023, Molecular oncology.